menu icon
REVOPSIS

About Us

Our ophthalmology and antibody development roots go deep. Our team is comprised of doctors, scientists, and business leaders that lead the seminal discovery, development, and commercialization of revolutionary biologics for the treatment of retinal vascular diseases. We are now focusing our Rev-Mod Platform to build a pipeline of multispecific biologics that address unmet needs in opthalmology and to solve blindness worldwide.

The possibilities of our Rev-Mod Platform are nearly limitless. Learn more about partnering with us to advance therapeutic development in other therapeutic areas.

Learn more

Management Team

Ramanath Bhandari, MD, FASRS

Founder, Board
& Interim CEO/Chairman

Ramesh Bhatt, PhD

CSO

Li Xu, PhD

Lead Scientist

Board of Directors

Ramanath Bhandari, MD, FASRS

Founder, Board
& Interim CEO/Chairman

Jeff Olson, MD

Founder & Board of Directors

Ram Palanki, PharmD

Board of Directors

Scientific Advisors

Arshad M. Khanani, MD, MA, FASRS

Advisor

Mark Barakat, MD, FASRS

Advisor

Peter K. Kaiser, MD, FASRS

Advisor

Jeff Heier, MD, FASRS

Advisor